ZOLADEX (AstraZeneca Pharmaceuticals LP)


Welcome to the PulseAid listing for the ZOLADEX drug offered from AstraZeneca Pharmaceuticals LP. This Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AstraZeneca Pharmaceuticals LP
NON-PROPRIETARY NAME: Goserelin acetate
SUBSTANCE NAME: GOSERELIN ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: IMPLANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-05-05
END MARKETING DATE: 0000-00-00


ZOLADEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZOLADEX from AstraZeneca Pharmaceuticals LP
LABELER NAME: AstraZeneca Pharmaceuticals LP
DEA SCHEDULE:
ACTIVE STRENGTH: 3.6(mg/1)
START MARKETING DATE: 2003-05-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0310-0950_aa22eb64-3073-4975-b10b-786e82961b7b
PRODUCT NDC: 0310-0950
APPLICATION NUMBER: NDA019726

Other GOSERELIN ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AstraZeneca Pharmaceuticals LPZOLADEX